Atherosclerosis in thrombotic primary antiphospholipid syndrome

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 4, 2009, Pages 537-542

  Ames, Paul R J ^a,d   Antinolfi, I ^b   Scenna, G ^b   Gaeta, G ^b   Margaglione, M ^c   Margarita, A ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b CARDARELLI HOSPITAL   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d NONE   (United Kingdom)

Author keywords

Antiphospholipid antibodies; Atherosclerosis; Intima media thickness

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID ANTIBODY; TRIACYLGLYCEROL; WARFARIN;

ADULT; AGE; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA PROLIFERATION; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CLINICAL FEATURE; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; THROMBOPHILIA; THROMBOSIS;

EID: 63049111253     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03308.x     Document Type: Article

References (23)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Westerweel PE, Luyten RKMAC, Koomans HA, Derksen RHWM, Verhaar MC. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1384-96.
3. Frostegård J. Systemic lupus erythematosus and cardiovascular disease. Lupus 2008; 17: 364-7.
4. Meroni PL, Peyvandi F, Foco L, Bernardinelli L, Fetiveau R, Mannucci PM, Tincani A. Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women. J Thromb Haemost 2007; 5: 2421-8.
5. Medina G, Casaos D, Jara LJ, Vera-Lastra O, Fuentes M, Barile L, Salas M. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003; 62: 607-10.
6. Ames PRJ, Margarita A, Sokoll KB, Iannaccone L, Brancaccio V. Atherosclerosis in primary antiphospholipid syndrome. Preliminary data. Ann Rheum Dis 2005; 64: 315-7.
7. Der H, Kerekes G, Veres K, Szodoray P, Toth J, Lakos G, Szegedi G, Soltesz P. Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 2007; 16: 497-503.
8. Bilora F, Boccioletti V, Girolami B, Zanon E, Armani M, Petrobelli F, Girolami A. Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost 2002; 8: 103-13.
9. Jiménez S, García-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, Zambón D, Ros E, Bru C, Font J. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2005; 44: 756-61.
10. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-15.
11. Brancaccio V, Ames PRJ, Glynn J, Iannaccone L, Mackie IJ. A rapid screen for lupus anticoagulant (LA) by comparing a sensitive and insensitive aPTT reagent provides also good discrimination from oral anticoagulants, congenital factor deficiency and heparin. Blood, Coag & Fibrinolysis 1997; 8: 155-60.
12. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995; 26: 386-91.
13. Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol 1999; 83: 1490-4.
14. Sangle SR, D'Cruz DP, Jan W, Karim MY, Khamashta MA, Abbs IC, Hughes GRV. Renal artery stenosis in the antiphospholipid syndrome and hypertension. Ann Rheum Dis 2003; 62: 999-1002.
15. Finazzi G, Brancaccio V, Moia M, Ciavarella N, Mazzucconi MG, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
16. Girón-González JA, García del Río E, Rodríguez C, Rodríguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: Prospective analysis of 404 individuals. J Rheumatol 2004; 31: 1560-7.
17. Ames PRJ, Ciampa A, Margaglione M, Iannaccone L, Scenna G, Brancaccio V. Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation. An 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. Thromb Haemost 2005; 93: 694-9.
18. Reshetniak TM, Alekberova ZS, Kotel'nikova GP, Aleksandrova EN, Mach ES, Radenska-Lopovok SG, Kalashnikova LA, Nasonova VA. Survival and prognostic factors of death risk in antiphospholipid syndrome: Results of 8-year follow-up. Ter Arkh 2003; 75: 46-51.
19. Margarita A, Batuca J, Scenna G, Delgado Alves J, Lopez L, Iannaccone L, Matsuura E, Ames PRJ. Subclinical atherosclerosis in primary antiphospholipid syndrome. Ann N Y Acad Sci 2007; 1108: 475-80.
20. Nityanand S, Bergmark C, de Faire U, Swedenborg J, Holm G, Lefvert AK. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 1995; 238: 437-43.
21. Delgado Alves J, Ames PRJ, Donohue S, Norouz-Zadeh J, Isenberg DA. Antibodies towards high density lipoprotein, apo-A-I and cardiolipin inversely correlate to para-oxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Possible atherogenic mechanisms. Arthritis Rheum 2002; 46: 2686-94.
22. Ames PRJ, Batuca J, Delgado Alves J, Margarita A, Lopez L, Iannaccone L, Scenna G, Matsuura EE. Primary antiphospholipid syndrome: A low-grade auto-inflammatory disease? Rheumatology 2008; 47: 1832-7.
23. Ames PRJ, Margarita A, Delgado Alves J, Tommasino C, Iannaccone L, Brancaccio V. Anticardiolipin antibody titre and plasma homocysteine independently predict intima-media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002; 11: 208-14.